171 related articles for article (PubMed ID: 33776440)
1. A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study.
Li Y; Zhang L; Zhang Y; Wen H; Huang J; Shen Y; Li H
Neuropsychiatr Dis Treat; 2021; 17():847-857. PubMed ID: 33776440
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, clinical correlates, and social functions of Chinese schizophrenia patients with drug-induced parkinsonism: A cross-sectional analysis of a multicenter, observational, real-world, prospective cohort study.
Weng J; Zhang L; Yu W; Zhao N; Zhu B; Ye C; Zhang Z; Ma C; Li Y; Yu Y; Li H
Front Pharmacol; 2023; 14():1077607. PubMed ID: 36937864
[No Abstract] [Full Text] [Related]
3. Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia.
Ohnishi T; Wakamatsu A; Kobayashi H
Neuropsychiatr Dis Treat; 2021; 17():1095-1104. PubMed ID: 33888985
[TBL] [Abstract][Full Text] [Related]
4. Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.
Patrick DL; Burns T; Morosini P; Rothman M; Gagnon DD; Wild D; Adriaenssen I
Curr Med Res Opin; 2009 Feb; 25(2):325-38. PubMed ID: 19192977
[TBL] [Abstract][Full Text] [Related]
5. Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia.
Vauth R; Carpiniello B; Turczyński J; Ivanov M; Cherubin P; Lahaye M; Schreiner A
Int J Methods Psychiatr Res; 2021 Jun; 30(2):e1855. PubMed ID: 33355966
[TBL] [Abstract][Full Text] [Related]
6. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia.
Jelastopulu E; Giourou E; Merekoulias G; Mestousi A; Moratis E; Alexopoulos EC
BMC Psychiatry; 2014 Jul; 14():197. PubMed ID: 25005616
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
9. Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms.
García-Portilla MP; García-Álvarez L; González-Blanco L; Dal Santo F; Bobes-Bascarán T; Martínez-Cao C; García-Fernández A; Sáiz PA; Bobes J
Front Psychiatry; 2021; 12():700747. PubMed ID: 34434128
[No Abstract] [Full Text] [Related]
10. Predictive factors of functional capacity and real-world functioning in patients with schizophrenia.
Menendez-Miranda I; Garcia-Portilla MP; Garcia-Alvarez L; Arrojo M; Sanchez P; Sarramea F; Gomar J; Bobes-Bascaran MT; Sierra P; Saiz PA; Bobes J
Eur Psychiatry; 2015 Jul; 30(5):622-7. PubMed ID: 25681175
[TBL] [Abstract][Full Text] [Related]
11. Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study.
Correll CU; Stanford AD; Claxton A; Du Y; Weiden PJ
Psychiatry Res; 2019 Apr; 274():176-181. PubMed ID: 30802689
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
[TBL] [Abstract][Full Text] [Related]
13. [Negative symptoms predict the improvement of social functioning of patients with schizophrenia].
He Q; Chen Y; Chow SL; Huang MM; Zhang ZQ; Zhang SS; Shen WW; Deng H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):284-8. PubMed ID: 24749359
[TBL] [Abstract][Full Text] [Related]
14. Effects of paliperidone extended release on the symptoms and functioning of schizophrenia.
Huang MW; Yang TT; Ten PR; Su PW; Wu BJ; Chan CH; Lan TH; Liu IC; Chiu WC; Li CY; Cheng KS; Yeh YC
BMC Clin Pharmacol; 2012 Jan; 12():1. PubMed ID: 22225965
[TBL] [Abstract][Full Text] [Related]
15. An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis.
Si T; Tan Q; Zhang K; Wang Y; Rui Q
Neuropsychiatr Dis Treat; 2015; 11():87-95. PubMed ID: 25657581
[TBL] [Abstract][Full Text] [Related]
16. Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China.
Zhang L; Li YG; He S; Zhang Y; Yu YM; Li Y; Wen H; Qiao Y; Shen YF; Li HF
Acta Pharmacol Sin; 2019 Dec; 40(12):1611-1620. PubMed ID: 31388088
[TBL] [Abstract][Full Text] [Related]
17. Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia.
Weng J; Zhang Y; Li H; Shen Y; Yu W
Gen Psychiatr; 2019; 32(1):e100026. PubMed ID: 31179423
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
[TBL] [Abstract][Full Text] [Related]
19. Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation.
Si TM; Zhang YL; Feng Y; Zhuo JM; Cai S; Zhang L
Psychiatry Res; 2019 Apr; 274():301-305. PubMed ID: 30831454
[TBL] [Abstract][Full Text] [Related]
20. Personal and social functioning in schizophrenia: defining a clinically meaningful measure of maintenance in relapse prevention.
Nicholl D; Nasrallah H; Nuamah I; Akhras K; Gagnon DD; Gopal S
Curr Med Res Opin; 2010 Jun; 26(6):1471-84. PubMed ID: 20402565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
